One moment please...



Neurofeedback in ADHD & Insomia

Scientific Publications

Neurofeedback, following protocols outlined and used by the neuroCare Group, is an effective method of treating ADHD and sleep disorders. neuroCare Group actively partners with several research institutions worldwide, to better understanding the effects of neurofeedback in the ADHD population (both in children and adults). See below for further details and quality assurance of the neuroCare approach to delivering evidence-based neurofeedback protocols.

Van Doren et al. 2018

Sustained effects of neurofeedback in ADHD: a systematic review and meta-analysis

This is a systematic review and meta-analysis which looks at data from more than 500 children with ADHD from 10 randomised controlled trials, comparing the effects of Neurofeedback with ‘active treatments’ (including medication and ‘non-active’ (no treatment) conditions. To critically interpret the data, researchers with different views on Neurofeedback contributed to this study. They concluded that Neurofeedback had long-lasting effects after an average of 6 months, with no ongoing therapy sessions needed after the initial program compared to the group which was still taking medication at follow-up, and at follow-up, the effects of neurofeedback were comparable to the effects of medication.




Strehl et al. 2017

Neurofeedback of Slow Cortical Potentials in Children with ADHD: A Multicenter Randomized Trial Controlling for Unspecific Effects

This is the largest multi-centre randomised study on SCP Neurofeedback, in 150 children with ADHD. The study confirms the specific efficacy of SCP neurofeedback on the core symptoms of ADHD compared to a semi-active control group. This demonstrates the feasibility and, above all, the efficacy of SCP neurofeedback in children with ADHD, controlling for specific and unspecific effects.




Krepel et al. 2020

A multicenter effectiveness trial of QEEG-informed neurofeedback in ADHD: Replication and treatment prediction





Arns et al. 2012

The Effects o QEEG-Informed Neurofeedback in ADHD: An Open-Label Pilot Study

This paper demonstrates the results of the ‘individualized’ neurofeedback approach – also called QEEG informed neurofeedback – which is employed within neuroCare Clinics worldwide. This manuscript also summarises how personalisation of neurofeedback treatment, both within this study and in an earlier study by an independent group, potentially doubles clinical treatment effects.




Ryan et al. 2019

What’s Sleep Got To Do with it? Circadian Rhythm Sleep Disorder, ADHD and Neurofeedback

Dr Ryan exlores the role of sleep in ADHD to explain the positive effects of Neurofedback as a treatment option in this patient group.


neuroCare Clinics Australia

Experienced providers of Neurofeedback now in Australia. Clinics across Sydney and Melbourne.

Find a Clinic

Would you like to find out more about our Neurofeedback programs?

Submit your enquiry today and one of our experienced staff will be in touch to explain the next steps.

Logo neuroCare bunt Poster vector white 1

neuroCare is innovating mental health and performance by personalising therapy following a detailed assessment. neuroCare’s objective, measurable and effective approach is based on our natural ability to learn (neuroplasticity) and technology to accelerate the learning (neuromodulation).

To learn more about what we do worldwide
www.neurocaregroup.com

neuroCademy Professional Training & Science
www.neurocademy.com

Copyright neuroCare Group Pty Ltd. 2020. All rights reserved.


Digital Agency - Supple
Call Now ButtonCall now